TauroLock™ in Parenteral Nutrition TauroLock™ in Parenteral Nutrition prevents infections with excellent tolerability and cost savings PN in small children CRI per 1000 catheter days, p < 0.05
1.06
12 10 8 6 4
5.5
2 0
Saline
0.5
Clark et al. 2019
C 3.2 ost s 00 avin wit € p gs hT o aur er pa f oLo tien ck™ t
12 10 8 6 4 2 0
16 14
14.3
Łyszkowska et al. 2019
16 14
PN and Chemotherapy in Children in Australia CRI per 1000 catheter days, p = 0.0001
Heparin 10 U/ml
SH1000 BH48 BH1CC JE2
20.000 15.000
p < 0.05
10.000 Hogan et al. 2016
[Fluoresent intensity units]
Viability of mature biofilms
„TauroLock™...inactivated Staph. aureus biofilms at all time points investigated“
5.000 0
U
ol
ck
ed
t ea r t n
D
o al ur
+E
n tha
TA
ED
k
an
Bl
TauroLock™ lock solutions in clinical studies: • Prevent catheter-related bloodstream infections. 2,3,4 • Are safe for the patient. 2,3 • Save costs. 2,4 • After millions of applications no catheter damage was observed since 2004.
84401GB/25/21
+ For side-effects of Ethanol like „plasma protein precipitation, and increased risk of thrombosis, catheter damage and systemic toxicity...“ see ref. 5,6 and others.